# Nuclide record sentinel-node-mapping (indication). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/indications/sentinel-node-mapping/>
  a schema:MedicalCondition ;
  nuclide:kind "indication" ;
  schema:identifier "sentinel-node-mapping" ;
  schema:name "Sentinel lymph node mapping in breast cancer and melanoma"@en ;
  schema:description "Before removing lymph nodes to check whether a breast cancer or melanoma has spread, surgeons inject a small radioactive tracer that flows to the very first node the tumour would reach, so only that node needs to come out to find the answer."@en ;
  schema:url <https://nuclide.cc/indications/sentinel-node-mapping/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://snmmi.org/common/Uploaded%20files/Web/Clinical%20Practice/Procedure%20Standards/2013/Final%20Breast%20Sentinel%20Node%20Guideline.pdf>, <https://snmmi.org/common/Uploaded%20files/Web/Clinical%20Practice/Procedure%20Standards/2015/2015_EANM_PracticeGL_Lymphoscintigraphy.pdf>, <https://tech.snmjournals.org/content/48/4/315> ;
  nuclide:tag "surgery", "SPECT", "breast", "melanoma" ;
  nuclide:related <https://nuclide.cc/isotopes/tc-99m/> ;
  nuclide:drugs <https://nuclide.cc/drugs/tilmanocept-tc99m/> ;
  nuclide:terms <https://nuclide.cc/terms/sentinel-lymph-node-biopsy/> .
